BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 17142723)

  • 21. Keratinocyte-associated B7-H1 directly regulates cutaneous effector CD8+ T cell responses.
    Ritprajak P; Hashiguchi M; Tsushima F; Chalermsarp N; Azuma M
    J Immunol; 2010 May; 184(9):4918-25. PubMed ID: 20363965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blockade of B7-H1 on macrophages suppresses CD4+ T cell proliferation by augmenting IFN-gamma-induced nitric oxide production.
    Yamazaki T; Akiba H; Koyanagi A; Azuma M; Yagita H; Okumura K
    J Immunol; 2005 Aug; 175(3):1586-92. PubMed ID: 16034097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of programmed death 1 ligands by murine T cells and APC.
    Yamazaki T; Akiba H; Iwai H; Matsuda H; Aoki M; Tanno Y; Shin T; Tsuchiya H; Pardoll DM; Okumura K; Azuma M; Yagita H
    J Immunol; 2002 Nov; 169(10):5538-45. PubMed ID: 12421930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Target-dependent B7-H1 regulation contributes to clearance of central nervous system infection and dampens morbidity.
    Phares TW; Ramakrishna C; Parra GI; Epstein A; Chen L; Atkinson R; Stohlman SA; Bergmann CC
    J Immunol; 2009 May; 182(9):5430-8. PubMed ID: 19380790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tissue expression of PD-L1 mediates peripheral T cell tolerance.
    Keir ME; Liang SC; Guleria I; Latchman YE; Qipo A; Albacker LA; Koulmanda M; Freeman GJ; Sayegh MH; Sharpe AH
    J Exp Med; 2006 Apr; 203(4):883-95. PubMed ID: 16606670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Forced expression of programmed death-1 gene on T cell decreased the incidence of type 1 diabetes.
    Won TJ; Jung YJ; Kwon SJ; Lee YJ; Lee DI; Min H; Park ES; Joo SS; Hwang KW
    Arch Pharm Res; 2010 Nov; 33(11):1825-33. PubMed ID: 21116786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RNA interference targeting programmed death receptor-1 improves immune functions of tumor-specific T cells.
    Borkner L; Kaiser A; van de Kasteele W; Andreesen R; Mackensen A; Haanen JB; Schumacher TN; Blank C
    Cancer Immunol Immunother; 2010 Aug; 59(8):1173-83. PubMed ID: 20349059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deficiency in B7-H1 (PD-L1)/PD-1 coinhibition triggers pancreatic beta-cell destruction by insulin-specific, murine CD8 T-cells.
    Rajasalu T; Brosi H; Schuster C; Spyrantis A; Boehm BO; Chen L; Reimann J; Schirmbeck R
    Diabetes; 2010 Aug; 59(8):1966-73. PubMed ID: 20484136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD4 T-cell help programs a change in CD8 T-cell function enabling effective long-term control of murine gammaherpesvirus 68: role of PD-1-PD-L1 interactions.
    Dias P; Giannoni F; Lee LN; Han D; Yoon S; Yagita H; Azuma M; Sarawar SR
    J Virol; 2010 Aug; 84(16):8241-9. PubMed ID: 20534854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Striking dichotomy of PD-L1 and PD-L2 pathways in regulating alloreactive CD4(+) and CD8(+) T cells in vivo.
    Habicht A; Kewalaramani R; Vu MD; Demirci G; Blazar BR; Sayegh MH; Li XC
    Am J Transplant; 2007 Dec; 7(12):2683-92. PubMed ID: 17924994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD4 T cells promote rather than control tuberculosis in the absence of PD-1-mediated inhibition.
    Barber DL; Mayer-Barber KD; Feng CG; Sharpe AH; Sher A
    J Immunol; 2011 Feb; 186(3):1598-607. PubMed ID: 21172867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Programmed cell death 1 (PD-1) regulates the effector function of CD8 T cells via PD-L1 expressed on target keratinocytes.
    Okiyama N; Katz SI
    J Autoimmun; 2014 Sep; 53():1-9. PubMed ID: 25047812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PD-L1 and PD-L2 modulate airway inflammation and iNKT-cell-dependent airway hyperreactivity in opposing directions.
    Akbari O; Stock P; Singh AK; Lombardi V; Lee WL; Freeman GJ; Sharpe AH; Umetsu DT; Dekruyff RH
    Mucosal Immunol; 2010 Jan; 3(1):81-91. PubMed ID: 19741598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dendritic cell programming by cytomegalovirus stunts naive T cell responses via the PD-L1/PD-1 pathway.
    Benedict CA; Loewendorf A; Garcia Z; Blazar BR; Janssen EM
    J Immunol; 2008 Apr; 180(7):4836-47. PubMed ID: 18354207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blockade of B7-H1 suppresses the development of chronic intestinal inflammation.
    Kanai T; Totsuka T; Uraushihara K; Makita S; Nakamura T; Koganei K; Fukushima T; Akiba H; Yagita H; Okumura K; Machida U; Iwai H; Azuma M; Chen L; Watanabe M
    J Immunol; 2003 Oct; 171(8):4156-63. PubMed ID: 14530338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PD-1 ligands expressed on myeloid-derived APC in the CNS regulate T-cell responses in EAE.
    Schreiner B; Bailey SL; Shin T; Chen L; Miller SD
    Eur J Immunol; 2008 Oct; 38(10):2706-17. PubMed ID: 18825752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Programmed death 1 ligand (PD-L) 1 and PD-L2 limit autoimmune kidney disease: distinct roles.
    Menke J; Lucas JA; Zeller GC; Keir ME; Huang XR; Tsuboi N; Mayadas TN; Lan HY; Sharpe AH; Kelley VR
    J Immunol; 2007 Dec; 179(11):7466-77. PubMed ID: 18025191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cutting edge: Programmed death-1/programmed death ligand 1 interaction regulates the induction and maintenance of invariant NKT cell anergy.
    Chang WS; Kim JY; Kim YJ; Kim YS; Lee JM; Azuma M; Yagita H; Kang CY
    J Immunol; 2008 Nov; 181(10):6707-10. PubMed ID: 18981087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A missing PD-L1/PD-1 coinhibition regulates diabetes induction by preproinsulin-specific CD8 T-cells in an epitope-specific manner.
    Schuster C; Brosi H; Stifter K; Boehm BO; Schirmbeck R
    PLoS One; 2013; 8(8):e71746. PubMed ID: 23977133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Programmed death ligand 1 regulates a critical checkpoint for autoimmune myocarditis and pneumonitis in MRL mice.
    Lucas JA; Menke J; Rabacal WA; Schoen FJ; Sharpe AH; Kelley VR
    J Immunol; 2008 Aug; 181(4):2513-21. PubMed ID: 18684942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.